HIV-1 Nef affects the trafficking of numerous cellular proteins to optimize viral replication and evade host defenses. The adaptor protein (AP) complexes, which form part of the cytoplasmic coat of endosomal vesicles, are key cellular co-factors for Nef. Nef binds these complexes and alters their physiologic cycle of attachment and release from membranes. Specifically, while AP-1 normally becomes cytosolic when attachment events are blocked by inhibition of the GTPase cycle of ADP-ribosylation factor-1 (ARF1), the complex remains membrane-associated in Nef-expressing cells. To investigate the mechanism of this effect, we used a permeabilized cell system to detect the de novo attachment of exogenous AP-1 to endosomal membranes. Nef did not mediate de novo attachment independently of ARF1, despite its ability to maintain the association of AP-1 with endosomal membranes when the activity of ARF1 was blocked. We conclude that Nef stabilizes AP complexes on endosomal membranes after ARF1-dependent attachment. This stabilization may facilitate coat formation and stimulate the trafficking of multiple cellular proteins. Published by Elsevier Inc.
Introduction
The nef gene of HIV-1 is required for high-level viremia and efficient pathogenesis in vivo (Deacon et al., 1995; Kestler et al., 1991) . This role in virulence is likely a consequence of directly optimized viral replication and evasion of the host immune response (Chowers et al., 1994; Collins et al., 1998) . The modulation of cellular protein trafficking underlies these effects. For example, Nef causes the removal from the cell surface of CD4, the primary receptor for HIV-1 (Garcia and Miller, 1991; Aiken et al., 1994) . This prevents the binding of the viral envelope glycoprotein to CD4, which might otherwise impair the release of virions from the plasma membrane and reduce the infectivity of progeny virions (Lama et al., 1999; Ross et al., 1999) . Nef also interferes with the presentation of viral antigens by down-regulating class I and class II major histocompatibility complexes from the cell surface, allowing viral evasion of the adaptive immune response (Stumptner-Cuvelette et al., 2001; Schwartz et al., 1996) .
Nef is a myristoylated, partly membrane-associated protein that interacts with members of a family of cellular vesicle coat proteins called adaptor protein (AP) complexes (Guy et al., 1987; Bresnahan et al., 1998) . Four different AP complexes have been identified, each potentially mediating protein transport between distinct intracellular compartments (Mellman, 1996; Hirst and Robinson, 1998) . AP-1 mediates transport between the trans-Golgi network (TGN) and the endosomal/lysosomal system, AP-2 between the plasma membrane and early/ sorting endosomes, AP-3 between the TGN or early endosomes and late endosomes/lysosomes, and AP-4 between the TGN and basolateral plasma membranes. HIV-1 Nef demonstrably interacts with AP-1 and AP-3, and this interaction requires a typical di-leucine-based sorting motif within Nef (Bresnahan et al., 1998; Janvier et al., 2003) .
In addition to simply interacting with AP complexes, Nef alters the dynamic cycle of their attachment and release from membranes (Janvier et al., 2003) . The attachment and release cycle of AP-1, AP-3, and AP-4 to membranes is regulated by the GTPase cycle of ADP-ribosylation factor 1 (ARF1) and by the phosphorylation status of the complex subunits (Ghosh and Kornfeld, 2003; Stamnes and Rothman, 1993; Simpson et al., 1997; Ooi et al., 1998; Traub et al., 1993) . The GTPase cycle of ARF1 regulates attachment. Guanine nucleotide exchange factors (GEFs) displace GDP from cytosolic ARF1 and replace it with GTP, inducing a myristoyl switch mechanism that exposes the N-terminus of the protein and allows its association with TGN and endosomal membranes (Donaldson and Klausner, 1994; Stamnes and Rothman, 1993; Goldberg, 1998) . Membrane-associated ARF1-GTP induces a transient, highaffinity docking site for the AP complexes (Zhu et al., 1998) . The mechanism of the formation of this docking site and its composition are uncertain. The site may include phosphoinositides, in particular phosphoinositol 4,5-bisphosphate (PIP2) and/ or phosphoinositol 4-phosphate [PI(4)P], which are required for the membrane-association of AP-1 (Crottet et al., 2002; Wang et al., 2003) . However, GTP-bound ARF1 can also bind the AP-1 (and AP-4) complex directly, suggesting that ARF1 itself may comprise the docking site (Austin et al., 2000; . Once the AP complexes are recruited from the cytosol to this membrane-docking site, binding to the sorting signals of transmembrane cargo proteins further stabilizes their association with membranes (Zhu et al., 1998) . GTPase-activating proteins (ARF1-GAPs) rapidly induce the hydrolysis of GTP to GDP, allowing the myristoyl group to fold back onto ARF1 and releasing ARF1 to the cytosol Goldberg, 1999) . Consequently, ARF1 is not a stoichiometric component of vesicles containing AP complexes, but rather seems to perform a catalytic function in initiating coat assembly (Zhu et al., 1998) . Phosphorylation of AP complex subunits regulates both the attachment and release of AP complexes from membranes (Ghosh and Kornfeld, 2003) . Dephosphorylation of the h subunit of AP-1 is associated with recruitment of AP-1 to membranes, and phosphorylation of the A1 subunit increases the affinity of AP-1 complexes for tyrosine-based sorting signals in transmembrane proteins. In contrast, dephosphorylation of A1 induces the release of AP-1 from membranes. This release is presumably a prerequisite for the fusion of transport vesicles with target membranes.
Under physiologic conditions, AP complexes undergo a rapid cycle of membrane attachment and release (Stamnes and Rothman, 1993; Simpson et al., 1997; Ooi et al., 1998; Traub et al., 1993) . The cellular pools of AP-1 and AP-3 become diffusely cytosolic within 2 to 5 min after cells are treated with brefeldin A (BFA), a fungal metabolite that blocks new attachment events by inhibiting ARF1 GEFs (Helms and Rothman, 1992) .
In contrast, in cells that express Nef, AP-1 and AP-3 remain bound to juxtanuclear, endosomal membranes for up to 30 min after new attachment events are blocked by BFA (Janvier et al., 2003) . This effect is most robust when Nef is expressed as the cytoplasmic domain of a transmembrane protein, such as CD8, which likely reflects the complete membrane-association of such chimeras. The membranes on which Nef stabilizes these complexes have not been identified unambiguously, but they are likely derived at least in part from perinuclear recycling endosomes, a compartment in which Nef resides and whose morphology Nef distorts . Nef also induces an abnormally persistent association of AP-1 and AP-3 with endosomal membranes in cells that express dominant-negative ARF1 (which sequesters ARF1 GEFs) or that over-express ARFGAP-1 (Janvier et al., 2003) . Biochemically, Nef does not appear to have ARF1-like or ARF1-GEF-like activity in vitro, either of which could have explained these effects (Janvier et al., 2003) . Furthermore, Nef neither stimulates ARF1-GEFs nor inhibits ARFGAP-1 (Janvier et al., 2003) . Although ARF1 has been reported to bind directly to Nef (Faure et al., 2004) , it is not recruited to the sites of Nef-mediated endosomal association of AP-1 in BFAtreated cells, suggesting that Nef does not mediate the association of AP complexes with membranes via ARF1 (Janvier et al., 2003) . Instead, the persistent attachment of the complexes to endosomal membranes requires the leucine-based sorting signal in Nef, indicating that direct binding to AP-1 and AP-3 is likely key to this activity (Janvier et al., 2003) .
Two mechanisms could account for the persistent membrane-attachment of AP-1 and AP-3 induced by Nef in BFAtreated cells: (1) Nef could induce a high-affinity binding site for the AP-1 and AP-3 complexes independently of ARF1; and/or (2) Nef could stabilize the complexes on membranes by blocking their release. To determine if Nef mediates ARF1-independent attachment, we used a system that detects the de novo attachment of exogenously added AP complexes to the membranes of permeabilized cells (Robinson and Kreis, 1992) . The results suggest that Nef does not mediate new attachment events independently of ARF1. We present a model in which Nef stabilizes the vesicle coat by inhibiting the release of AP complexes, leading to the increased inclusion of proteins such as CD4 in endosomal vesicles.
Results and discussion

GTP-locked ARF1 and Nef each induce the persistent attachment of AP-1 to endosomal membranes in brefeldin A (BFA)-treated hamster cells
To determine the mechanism by which Nef mediates the association of AP complexes with endosomal membranes, we modified a microscopic assay that detects the attachment of exogenously added AP complexes to the membranes of permeabilized target cells (Robinson and Kreis, 1992) . In this assay, a species-specific antibody that recognizes only the exogenously added complexes is used, so that the endogenous complexes in the target cells are not detected. We used baby hamster kidney (BHK) cells as target cells and HL-60 human monocytoid cells as the source of the exogenous AP complexes.
To ensure that this system was permissive for Nef-activity, we first determined whether BHK cells supported the Nef-mediated association of endogenous AP-1 with endosomal membranes. BHK-21 cells were transfected to transiently express either constitutively active (GTP-locked) ARF1 [ARF1-Q71L, which is defective for GTP hydrolysis, tagged with an influenza hemagglutinin (HA) epitope] or Nef as the cytoplasmic domain of a chimera containing the luminal and transmembrane portions of the CD8 a chain (CD8-Nef). The cells were treated with BFA for 5 min, fixed, immunostained for hamster g-adaptin (AP-1) and HA-ARF1-Q71L or CD8-Nef, and visualized by confocal immunofluorescence microscopy ( Fig. 1) . Both constitutively active ARF1 and Nef caused the endogenous AP-1 in BHK cells to remain membrane-associated despite the inhibition of ARF1-GEFs by BFA. AP-1 often co-localized with Nef on large, perinuclear vesicles. In contrast, the AP-1 in ARF1Q71L-or Nef-negative cells was uniformly dispersed throughout the cytosol by treatment with BFA. A CD8-Nef chimera in which the leucines of the Nef ExxxLL motif were replaced with alanines did not stabilize AP-1 on the endosomal membranes of BFAtreated BHK-21 cells, as described previously in HeLa cells (data not shown; Janvier et al., 2003) . These data indicated that hamster cells support the effects of Nef on the dynamics of AP complexes as first described in human cells (Janvier et al., 2003) .
Exogenous human AP-1 attaches to the internal membranes of permeabilized BHK cells Next, we determined whether exogenous human AP-1 complexes would attach to the internal membranes of permeabilized BHK cells. Human cytosol was prepared from HL-60 cells by freeze-thaw lysis and dounce homogenization followed by high-speed centrifugation. BHK-21 cells were permeabilized with digitonin in a potassium-based buffer. Then, HL-60 cytosol, supplemented with 1 mM GTP, 1 mM ATP, and an ATP-regeneration system consisting of creatine-phosphate and creatine phosphokinase was added and the cells were incubated for 5 min at 37 -C. The cells were washed once, fixed, immunostained with an antibody that recognizes human but not hamster g-adaptin (AP-1), and visualized by confocal immunofluorescence microscopy (Fig. 2) . In the absence of exogenous human cytosol, no staining was evident (panel a). When human cytosol was added, over 80% of the cells stained in a punctate, juxtanuclear, or perinuclear pattern consistent with the attachment of the exogenous complexes to endosomal membranes (panel b). This de novo attachment required the supplemental ATP noted above (data not shown). When the cells were treated with BFA for 5 min prior to permeabilization and when BFA was added to the human cytosol, the de novo attachment of the exogenous AP-1 was inhibited (panel c). HA-ARF1-Q71L or CD8-Nef. 24 h later, the cells were treated with BFA (10 Ag/ml) for 5 min, fixed, and immunostained for hamster g-adaptin (AP-1) and for HA or CD8. Insets show a portion of the image at higher magnification. Green: ARF Q71L or CD8-Nef; red: hamster AP-1. Each image is a single optical section acquired using a laser scanning confocal microscope. Fig. 2 . The de novo attachment of exogenous human AP-1 to the internal membranes of permeabilized BHK cells is sensitive to BFA. BHK-21 cells were permeabilized with digitonin, exposed to either buffer (a) or cytosol from human HL-60 cells (b), fixed, and stained for human g-adaptin. Cells in panel c were treated with BFA (10 Ag/ml) for 5 min before permeabilization, and BFA (10 Ag/ml) was included during the permeabilization and incubation of the cells with cytosol. The images are single optical sections acquired using a laser scanning confocal microscope.
Together, these results indicated that de novo attachment events can be monitored using permeabilized BHK cells and exogenous human adaptors from the cytosol of HL-60 cells; the results also indicated that these attachment events are sensitive to the inhibition of ARF1-GEFs by BFA.
ARF1-Q71L mediates the de novo attachment of exogenous human AP-1 to the internal membranes of permeabilized, BFA-treated BHK cells; Nef does not To determine whether Nef-mediated the ARF1-independent de novo attachment of AP-1, BHK-21 cells were transfected to transiently express HA-ARF1-Q71L or CD8-Nef, treated with BFA, permeabilized with digitonin, exposed to supplemented human cytosol as described above but including BFA, fixed, immunostained for human g-adaptin and HA-ARF1 or CD8-Nef, and visualized by confocal immunofluorescence microscopy (Fig. 3) . The GTP-locked ARF1-Q71L induced the attachment of human AP-1 to the internal membranes of the BHK cells despite the inhibition of ARF1-GEFs by BFA. In contrast, CD8-Nef did not induce the attachment of human AP-1 to the internal membranes of the BFA-treated BHK cells. These results suggested that the de novo attachment of AP-1 to endosomal membranes is dependent on ARF1 even in Nefexpressing cells.
In the absence of BFA, exogenous human AP-1 attaches to the endosomal membranes of permeabilized BHK cells exclusively at sites distinct from Nef
The preceding data suggested that although Nef mediates a persistent association of AP-1 with the endosomal membranes of BFA-treated BHK cells (Fig. 1) , it is unable to mediate ARF1-independent attachment events (Fig. 3) . These results are consistent with the hypothesis that Nef alters AP complex dynamics by inhibiting the release of the complexes from endosomal membranes.
To further test this hypothesis, de novo attachment experiments using BHK cells expressing ARF1-Q71L or CD8-Nef were repeated in the absence of BFA (Fig. 4) . We reasoned that if Nef inhibits the release of AP-1 from membranes by directly binding to the complex, then the binding sites on Nef might be saturated with endogenous hamster AP complexes and consequently would be unavailable to bind exogenous human AP-1. As in the experiment shown in Fig. 2 , most of the permeabilized BHK cells shown in Fig. 4 took up exogenous human AP-1. However, while much of the newly attached AP-1 co-localized with ARF1-Q71L, almost none co-localized with CD8-Nef. This exclusion of de novo attached human AP-1 from the sites of CD8-Nef is consistent with saturation of Nef with the endogenous, hamster AP complexes and a low rate of exchange with the exogenous, human complexes.
Native Nef as expressed from the HIV-1 genome stabilizes the association of AP-1 with endosomal membranes
The above experiments were performed using CD8-Nef to optimize the association of Nef with membranes and maximize the stabilization effect. To document that the stabilization of AP complexes on membranes is not wholly an artifact of the use of the CD8-Nef chimera, we expressed native Nef from the complete viral genome by transfecting BHK-21 cells with a proviral plasmid, pNL4-3. To detect Nef, we used a sheep antiserum for indirect immunofluorescence (Fig. 5) . Cells that were not transfected showed complete dispersal of AP-1 throughout the cytosol following 5 min of treatment with BFA (compare panels a and b, Fig. 5 ). In contrast, in approximately half of the cells expressing Nef, AP-1 remained concentrated in a juxtanuclear region, consistent with persistent association with endosomes (panels c and d, Fig. 5 ). These data Fig. 3 . ARF1-Q71L but not Nef induces the de novo attachment of exogenous human AP-1 to the internal membranes of permeabilized BHK cells in the presence of BFA. BHK-21 cells were transfected with HA-ARF1-Q71L or CD8-Nef. 24 h later, the cells were treated with BFA (10 Ag/ml), permeabilized with digitonin, exposed to cytosol from human HL-60 cells containing BFA (10 Ag/ml), fixed, and stained for human g-adaptin and HA or CD8. Green: ARF Q71L or CD8-Nef; red: human AP-1. The images are single optical sections acquired using a laser scanning confocal microscope.
indicated that the membrane stabilization effect seen with CD8-Nef is detectable with native Nef as expressed by the viral genome.
In summary, we investigated whether the Nef-mediated stabilization of AP-1 on endosomal membranes as revealed in BFA-treated cells is due to an ARF1-independent attachment process. Using a permeabilized cell system in which the de novo recruitment of exogenous AP-1 to endosomal membranes was visualized microscopically, we observed that Nef was unable to mediate ARF1-independent attachment events. These events appear to require ARF1 even in Nef-expressing cells. Furthermore, when ARF1-mediated attachment was not blocked, newly recruited exogenous AP-1 was excluded from sites occupied by Nef. This exclusion suggested that Nef was saturated with endogenous AP complexes and that the turnover rate of the complexes on Nef was significantly longer than the 1 is red (d) . Each image is a projection of a Z-series of optical sections acquired using a spinning disc confocal microscope and processed using ''no-neighbors'' deconvolution (SlideBook software; Intelligent Imaging Innovations). Fig. 4 . In the absence of BFA, exogenous human AP-1 attaches to the internal membranes of permeabilized BHK cells at sites co-incident with ARF1-Q71L but not co-incident with Nef. BHK-21 cells were transfected with HA-ARF1-Q71L or CD8-Nef. 24 h later, the cells were permeabilized with digitonin, exposed to cytosol from human HL-60 cells, fixed, and stained for human g-adaptin and HA or CD8. Insets show a portion of the image at higher magnification. Green: ARF Q71L or CD8-Nef; red: human AP-1. The images are single optical sections acquired using a laser scanning confocal microscope.
5-min timeframe of the experiment. In contrast, a GTP-locked ARF1 mutant, ARF1-Q71L, showed no evidence of saturation and was able to recruit exogenous AP-1 whether or not the GTPase cycle of native ARF1 was blocked.
These data demonstrate that Nef cannot be viewed mechanistically as a constitutively active viral version of ARF1. The ability of ARF1-Q71L to recruit exogenous complexes suggests an activity that generates high affinity docking sites in non-saturable numbers, perhaps based on changes in membrane phospholipids (Crottet et al., 2002; Wang et al., 2003) . In contrast, the inability of Nef to recruit exogenous complexes is consistent with a direct binding mechanism that is saturable by the endogenous complexes. We cannot exclude that Nef could induce ARF1-independent de novo attachment in the absence of saturating endogenous complexes. Such an effect might be demonstrable using donor cytosol from Nef-expressing cells or by adding purified myristoylated Nef to the donor cytosol during the de novo attachment experiments. Nevertheless, the data indicate that ARF1-independent attachment is not required for the observed altered dynamics of the complexes: when the GTPase cycle of ARF1 is blocked, new attachment events at sites containing Nef are not observed (Fig. 3 ), yet the membrane-association of endogenous complexes is stabilized (Fig. 1) . Furthermore, the apparent low turnover rate of AP-1 on Nef (Fig. 4) implies that the release of the endogenous AP complexes from endosomal membranes has been inhibited. The release of AP complexes from membranes is regulated at least in part by dephosphorylation (Ghosh and Kornfeld, 2003) . Although Nef might inhibit dephosphorylation events involved in complex release, we favor the hypothesis that the well documented direct binding between Nef and AP-1 (and AP-3) is the basis for the inhibition of the release of the complexes (Bresnahan et al., 1998; Janvier et al., 2003) . This hypothesis is supported by the observation that the residues required for the stabilization effect are either within or flanking the C-terminal loop of Nef, which contains a canonical leucine-based AP-binding motif (Janvier et al., 2003; Coleman et al., 2005) .
How might post-attachment stabilization of AP complexes contribute to the ability of Nef to affect the trafficking of multiple cellular transmembrane proteins? To answer this, it is important to note that the formation of transport vesicles appears to be a process regulated by the rapid association and disassociation of coat components. Furthermore, many coat association-events are abortive and do not lead to the formation of a vesicle (Ehrlich et al., 2004) . If Nef stabilizes AP complexes post-attachment, then nascent coats may be more likely to persist and allow the formation of transport vesicles. This model is in a broad sense consistent with the increased formation of clathrin coated pits observed along the plasma membrane of Nef-expressing cells (Foti et al., 1997) , although the specific AP complex in that case is presumably AP-2. In addition to increased vesicle-formation, prolonged membraneassociation of the AP complexes might allow more efficient inclusion of transmembrane proteins into the vesicles, especially those with relatively weak AP-binding signals or those that are present at relatively low concentrations. These considerations suggest a model in which Nef stabilizes AP complexes on membranes post-attachment, facilitating the interaction of modulated proteins with the complexes and enhancing their inclusion in transport vesicles (Fig. 6 ). These effects would be expected to cause alterations in the trafficking of numerous cellular proteins by Nef, as has now been well documented.
Materials and methods
Antibodies
The following antibodies were used: murine anti-g adaptin clone 88 (BD Biosciences) to recognize rodent g adaptin, murine anti-g adaptin clone 100/3 (Sigma) to recognize human Fig. 6 . Model in which Nef stabilizes the vesicle coat and enhances the trafficking of cellular proteins. Top: in the absence of Nef, a target protein such as CD4 is insufficient for the stabilization of the AP coat and the formation of transport vesicles; bottom: Nef stabilizes the AP coats, allowing low affinity targets such as CD4 to incorporate into vesicles, whose formation is also enhanced. g adaptin but not rodent, murine FITC-conjugated anti-CD8 (Jackson Laboratories), murine FITC-conjugated antihemagglutinin (Covance), a sheep antiserum raised to recombinant HIV-1 Nef NL4-3 (Pandori et al., 1996) , rhodamine X-conjugated goat anti-mouse IgG (Jackson Laboratories), and rhodamine Xconjugated donkey anti-sheep IgG (Jackson Laboratories).
HL-60 cytosol preparation
HL-60, human promyelocytic leukemia cells (5 Â 10 8 ; ATCC #CCL-240), were pelleted by centrifugation, resuspended in an equal volume of cytosol buffer (25 mM HEPES, 125 mM potassium acetate, 2.5 mM magnesium acetate, 1 mg/ ml glucose, pH 7.0), zap frozen by exposure to liquid nitrogen, thawed, and then dounce homogenized. The disrupted cells were then centrifuged at 100,000 Â g for 1 h. The supernatant was collected, frozen using liquid nitrogen, and stored at À80 -C until used. Protein concentration ranged between 10 and 15 mg/ml.
Nef-mediated membrane-association of adaptor complexes in living cells
Hamster kidney cells, BHK-21 (C-13; ATCC #CCL-10), were transfected with plasmids expressing either HA-ARF1 Q71L (Peters et al., 1995) , CD8-Nef (Erdtmann et al., 2000) , or the complete HIV-1 genome (pNL4-3; Adachi et al., 1986) using FuGene 6 (Roche). After 24 h, the cells were treated with 10 Ag/ml brefeldin A (Epicentre) for 5 min, then fixed with 3% paraformaldehyde and permeabilized with 0.1% NP-40. To stain AP-1 in cells expressing HA-ARF1 Q71L or CD8-Nef, the preparations were incubated with murine anti-g-adaptin (clone 88), then with Rhodamine X-conjugated goat antimouse IgG. After extensive washing to remove unbound secondary antibody, the cells were incubated with normal mouse serum to block exposed antigen binding sites on the bound goat anti-mouse IgG secondary antibody, then stained with FITC-conjugated anti-HA or FITC-conjugated anti-CD8. The cells were then analyzed using a laser scanning, confocal fluorescence microscope (BioRad Radiance). To stain AP-1 in cells expressing native Nef from the NL4-3 genome, the preparations were first incubated simultaneously with murine anti-g-adaptin (clone 88) along with a sheep antiserum raised to Nef, then with Rhodamine X-conjugated donkey anti-mouse IgG along with FITC-conjugated donkey anti-sheep IgG. These cells were analyzed using a spinning disc confocal microscope (Olympus).
De novo recruitment of AP-1 to membranes of permeabilized cells BHK-21 cells (4 Â 10 4 ) were plated on 3-well ICN slides 24 h before transfection with either HA-ARF1 Q71L or CD8-Nef constructs using FuGene 6 (Roche). After 24 h, the cells were washed with cytosol buffer (see above), then permeabilized with 40 Ag/ml digitonin (Sigma) in cytosol buffer at 4 -C for 10 min, and again washed with cytosol buffer. HL-60 cytosol supplemented with 1 mM ATP, 1 mM GTP, 16 mM phosphocreatine (Sigma), and 0.1 mg/ml creatine kinase (Roche) was added and the permeabilized cells were incubated at 37 -C for 5 min. The cells were washed with cytosol buffer and then fixed with 3% paraformaldehyde in cytosol buffer for 1 h at room temperature. The cells were washed with cytosol buffer and then re-permeabilized with 0.1% NP40 in cytosol buffer. Immunostaining was conducted as described above except that murine anti-g adaptin clone 100/3 was used as the primary antibody to recognize only human g-adaptin, and the cells were analyzed by laser scanning, confocal microscopy. To block de novo attachment of AP-1 mediated by endogenous ARF1, the cells were treated with 10 Ag/ml brefeldin A (Epicentre) for 5 min at 37 -C just before the initial permeabilization, and 10 Ag/ml BFA was included at each subsequent step of the procedure until aldehyde-fixation.
